SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-033398
Filing Date
2020-07-24
Accepted
2020-07-24 16:45:25
Documents
12
Period of Report
2020-07-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20200723.htm   iXBRL 8-K 34727
  Complete submission text file 0001564590-20-033398.txt   160373

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acor-20200723.xsd EX-101.SCH 5768
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20200723_lab.xml EX-101.LAB 18732
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20200723_pre.xml EX-101.PRE 11167
5 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20200723_htm.xml XML 3419
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 201047337
SIC: 2836 Biological Products, (No Diagnostic Substances)